SCHEMBL5136170

SCHEMBL5136170

CN(C(=O)c1ccccc1CC1CCOC1)C1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 14/20 0.44
SLC6A2 P23975 12/20 0.44
SLC6A3 Q01959 9/20 0.44
KCNH2 Q12809 4/20 0.43
HSD11B1 P28845 1/20 0.41
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
CHRM1 P11229 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
CYP2D6 P10635 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
NSD2 O96028 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5190868 0.83 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3KCNH2HSD11B1
SCHEMBL21590173 0.74 CNR1 (0.44) HPGDTSHRCNR1CNR2
SCHEMBL5135452 0.72 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3KCNH2HSD11B1
SCHEMBL5134527 0.72 SLC6A4 (0.39) SLC6A4SLC6A2SLC6A3KCNH2HSD11B1
SCHEMBL23228757 0.71 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3
SCHEMBL5140427 0.70 SLC6A4 (0.38) SLC6A4SLC6A2SLC6A3KCNH2HSD11B1
SCHEMBL19969993 0.70 CNR1 (0.41) CNR1CNR2
SCHEMBL10107580 0.70 SLC6A4 (0.64) SLC6A4SLC6A2SLC6A3KCNH2HPGD
SCHEMBL30514759 0.69 TSHR (0.47) SLC6A4SLC6A2SLC6A3KCNH2HSD11B1
SCHEMBL4291607 0.69 SLC6A4 (0.50) SLC6A4SLC6A2SLC6A3KCNH2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901746-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS Merck & Co., Inc. (US) 2008-03-26 EP disclosed
WO-2007002884-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2007-01-04 WO disclosed